10-Q · May 14, 2026
Lifeway Foods, Inc. reported a notable increase in Q1 2026 revenue to $63.0 million, a 36.7% increase from $46.1 million in Q1 2025. The diluted EPS rose to $0.31, surpassing both the prior year’s EPS of $0.23 and…
Earnings analysis · 10-Q
LWAY earnings analysis
Filed August 13, 2026 · Our reading of the company's report
The latest report
The supplied 10-Q excerpt does not include the income statement, balance sheet, cash-flow statement, segment results, or MD&A, so current-period financial metrics cannot be determined from the provided filing text. It…
Read full summary
The supplied 10-Q excerpt does not include the income statement, balance sheet, cash-flow statement, segment results, or MD&A, so current-period financial metrics cannot be determined from the provided filing text. It reports effective disclosure controls as of June 30, 2026 and no material internal-control changes. The filing also discloses a June 30, 2026 secured funding agreement and a May offering involving 3,454,756 shares, alongside a 253,153-share repurchase at $19.50 per share.
Gross and operating margin
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
What stood out
-
Controls assessed effective
Management concluded that disclosure controls and procedures were effective as of June 30, 2026, with the evaluation performed by the CEO and CFO.
-
Share repurchase completed
The company repurchased 253,153 shares at $19.50 per share during fiscal year 2026, according to the issuer-purchase table.
-
Offering and repurchase disclosed
The May 19, 2026 offering involved 3,454,756 shares sold by Danone USA Public Benefit Corporation at $19.50 per share; Lifeway repurchased 253,153 shares in the offering.
-
No material control changes
The company reported no changes during the quarter that materially affected, or were reasonably likely to materially affect, internal control over financial reporting.
What to watch
-
New secured funding arrangement
The company entered into a Master Security Agreement, Interim Funding Agreement, and Equipment Guidance Line Note with CIBC Bank USA dated June 30, 2026. The supplied excerpt does not disclose the facility amount or outstanding balance.
-
Cash used for share repurchase
Lifeway repurchased 253,153 shares at $19.50 per share in connection with the offering, representing approximately $4.9 million of share purchases based on the disclosed price and share count.
-
No updated risk-factor disclosures
The filing states there were no material changes from the risk factors in the 2025 Form 10-K, so no newly identified risk-factor changes are disclosed in the supplied text.
Management's outlook
The supplied 10-Q text does not provide quantitative revenue or EPS guidance. Prior full-year revenue guidance of $250 million to $260 million was reported in the prior analysis, but its status is not stated in the supplied filing excerpt.
Earlier filings 4
10-K · March 17, 2026
Lifeway reports record net sales of $212,496,000 in 2025, up from $186,820,000 in 2024, driven by its core drinkable kefir franchise which represented 85% of 2025 net sales ($181,423,000). The company emphasizes product…
10-Q · November 14, 2024
Lifeway reported quarterly revenue of $46,095,000 (three months ended September 30, 2024), up from $40,896,000 a year ago, while diluted EPS declined to $0.19 from $0.23. Operating income fell to $4,189,000 from…
10-Q · August 13, 2024
Lifeway reported a strong quarter ended June 30, 2024 with net sales of $49,157 (three months) vs $39,230 a year ago (+$9,927, +25.3%) and income from operations of $5,386. Profitability and EPS improved versus the…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.